Related by context. Frequent words. (Click for all words.) 68 Initiates Phase II 67 Co BMY 65 sanofi aventis GlaxoSmithKline 63 Completes Patient Enrollment 63 staphylococcal vaccines 62 Presents Positive 61 Engerix B 60 Receives Orphan Drug Designation 60 Vytorin combines 60 Zerit 60 Co MRK 60 Inc Therapeutic Competitors 60 Corp. Nasdaq GENZ 59 NYSE PFE 59 Copegus R 59 Respiratory Syncytial Virus RSV 59 Welcomes Analyst Initiation 59 gets USFDA nod 59 Drug Shows Promise 59 Synflorix 59 oncolytic virus therapies 59 Meets Primary Endpoint 58 Rotavirus Vaccine 58 R sorafenib tablets 58 Completes Enrollment 58 PROFILE CO 58 Epilepsy Drug 58 www.gsk.com 58 http:/www.gsk.com 57 Epivir 57 Nasdaq BIIB 57 Fluzone vaccine 57 nyse PFE news 57 interferon gamma 1b 57 Nasdaq AMGN 57 Enrolls First 56 visit www.bms.com 56 Tibotec Pharmaceuticals Ltd. 56 Therapeutic Competitors 56 FDA Accepts 56 Motavizumab 56 diphtheria tetanus pertussis 56 Develop Novel 56 #-# Full Text 56 Crucell NV NYSE Euronext 56 JAK inhibitor 56 rheumatoid arthritis psoriatic arthritis 56 antibiotic Zithromax 55 Cethromycin 55 b Hib 55 GlaxoSmithKline plc NYSE 55 Canvaxin 55 Approaching Resistance 55 Intelence 55 Analysts Upgrades Downgrades 55 Zolinza 55 Menactra vaccine 55 Sanofi Aventis Novartis 55 Earnings Postmortem 55 HIV integrase inhibitor 55 GRNVAC1 55 Denufosol 55 cardio renal 55 Guides Inline 54 Kenya Malawi Mozambique 54 Trovan 54 Nexavar sorafenib 54 BiTE R 54 Ixempra 54 Taiho Pharmaceutical 54 Boceprevir 54 VP Exercises Options 54 Bayer AG BAY GY 54 HPV cervical cancer 54 Progenics Pharmaceuticals 54 Tyzeka 54 Varivax 54 TO COMMENT 54 Bearish Pressure Building 54 Movers Roundup 54 Vertex Pharmaceuticals Inc 54 Drug Candidate 54 Exploit collaboration 54 Vicuron Pharmaceuticals 54 Influenza Vaccine 54 Accessed #/#/# [001] 54 Immune Tolerance Network 53 Takeda Kyowa Hakko Kirin 53 FluLaval 53 HMG CoA reductase inhibitors 53 TeGenero AG 53 Fluconazole 53 Director Exercises Options 53 Ixiaro 53 Halozyme Therapeutics 53 fostamatinib 53 Q2 Profit Surges 53 Penwest Pharmaceuticals 53 PATH Malaria Vaccine Initiative 53 SWOT Analysis www.companiesandmarkets.com adds 53 Q1 Loss Narrows